Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David H. Salat, Ph.D.

Co-Author

This page shows the publications co-authored by David Salat and Douglas Greve.
Connection Strength

1.728
  1. Serial Reaction Time Task Performance in Older Adults with Neuropsychologically Defined Mild Cognitive Impairment. J Alzheimers Dis. 2020; 74(2):491-500.
    View in: PubMed
    Score: 0.219
  2. Regional staging of white matter signal abnormalities in aging and Alzheimer's disease. Neuroimage Clin. 2017; 14:156-165.
    View in: PubMed
    Score: 0.178
  3. Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of aging. Neuroimage. 2016 05 15; 132:334-343.
    View in: PubMed
    Score: 0.167
  4. Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's disease. Neuroimage. 2011 Feb 01; 54(3):1795-802.
    View in: PubMed
    Score: 0.116
  5. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging. 2010 Feb; 31(2):244-56.
    View in: PubMed
    Score: 0.110
  6. Age-associated alterations in cortical gray and white matter signal intensity and gray to white matter contrast. Neuroimage. 2009 Oct 15; 48(1):21-8.
    View in: PubMed
    Score: 0.106
  7. Regional white matter volume differences in nondemented aging and Alzheimer's disease. Neuroimage. 2009 Feb 15; 44(4):1247-58.
    View in: PubMed
    Score: 0.101
  8. Age-related alterations in white matter microstructure measured by diffusion tensor imaging. Neurobiol Aging. 2005 Aug-Sep; 26(8):1215-27.
    View in: PubMed
    Score: 0.077
  9. Thinning of the cerebral cortex in aging. Cereb Cortex. 2004 Jul; 14(7):721-30.
    View in: PubMed
    Score: 0.073
  10. The Lifespan Human Connectome Project in Aging: An overview. Neuroimage. 2019 01 15; 185:335-348.
    View in: PubMed
    Score: 0.050
  11. Extending the Human Connectome Project across ages: Imaging protocols for the Lifespan Development and Aging projects. Neuroimage. 2018 12; 183:972-984.
    View in: PubMed
    Score: 0.050
  12. White matter abnormalities and cognition in patients with conflicting diagnoses and CSF profiles. Neurology. 2018 04 24; 90(17):e1461-e1469.
    View in: PubMed
    Score: 0.048
  13. Differential Regional Distribution of Juxtacortical White Matter Signal Abnormalities in Aging and Alzheimer's Disease. J Alzheimers Dis. 2017; 57(1):293-303.
    View in: PubMed
    Score: 0.044
  14. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters. Neurobiol Aging. 2015 Sep; 36(9):2447-57.
    View in: PubMed
    Score: 0.040
  15. Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people. Neurology. 2013 Sep 03; 81(10):904-9.
    View in: PubMed
    Score: 0.035
  16. Changes in white matter microstructure in patients with TLE and hippocampal sclerosis. Epileptic Disord. 2009 Sep; 11(3):244-50.
    View in: PubMed
    Score: 0.027
  17. Minute effects of sex on the aging brain: a multisample magnetic resonance imaging study of healthy aging and Alzheimer's disease. J Neurosci. 2009 Jul 08; 29(27):8774-83.
    View in: PubMed
    Score: 0.026
  18. Consistent neuroanatomical age-related volume differences across multiple samples. Neurobiol Aging. 2011 May; 32(5):916-32.
    View in: PubMed
    Score: 0.026
  19. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain. 2009 Aug; 132(Pt 8):2048-57.
    View in: PubMed
    Score: 0.026
  20. Predicting the location of entorhinal cortex from MRI. Neuroimage. 2009 Aug 01; 47(1):8-17.
    View in: PubMed
    Score: 0.026
  21. High consistency of regional cortical thinning in aging across multiple samples. Cereb Cortex. 2009 Sep; 19(9):2001-12.
    View in: PubMed
    Score: 0.026
  22. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009 Mar; 19(3):497-510.
    View in: PubMed
    Score: 0.025
  23. The relationship between diffusion tensor imaging and volumetry as measures of white matter properties. Neuroimage. 2008 Oct 01; 42(4):1654-68.
    View in: PubMed
    Score: 0.025
  24. Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity. Brain. 2008 Apr; 131(Pt 4):1057-68.
    View in: PubMed
    Score: 0.024
  25. Detection of cortical thickness correlates of cognitive performance: Reliability across MRI scan sessions, scanners, and field strengths. Neuroimage. 2008 Jan 01; 39(1):10-8.
    View in: PubMed
    Score: 0.023
  26. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology. 2005 Sep 13; 65(5):745-7.
    View in: PubMed
    Score: 0.020
  27. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology. 2005 Aug 09; 65(3):404-11.
    View in: PubMed
    Score: 0.020
  28. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol. 2004 Jul; 56(1):27-35.
    View in: PubMed
    Score: 0.019
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.